Vident Investment Advisory, LLC Abiomed Inc Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $102,573 - $127,517	423 Added 25.61%	2,075 $478,000
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $118,207 - $178,124	-526 Reduced 24.15%	1,652 $402,000
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $674,272 - $890,817	-2,432 Reduced 52.75%	2,178 $722,000
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $113,938 - $140,741	-379 Reduced 7.6%	4,610 $1.66 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $62,658 - $75,992	202 Added 4.22%	4,989 $1.62 Million
Q2 2021 Aug 13, 2021	SELL	$262.71 - $351.17 $121,109 - $161,889	-461 Reduced 8.78%	4,787 $1.49 Million
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $8,577 - $10,653	-30 Reduced 0.57%	5,248 $1.67 Million
Q4 2020 Feb 08, 2021	BUY	$251.88 - $324.2 $35,515 - $45,712	141 Added 2.74%	5,278 $1.71 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $432,853 - $537,632	1,696 Added 49.29%	5,137 $1.42 Million
Q2 2020 Jul 17, 2020	BUY	$141.4 - $257.09 $258,620 - $470,217	1,829 Added 113.46%	3,441 $831,000
Q1 2020 May 12, 2020	BUY	$130.51 - $196.01 $12,137 - $18,228	93 Added 6.12%	1,612 $234,000
Q4 2019 Feb 11, 2020	BUY	$159.31 - $223.54 $241,991 - $339,557	1,519 New	1,519 $259,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.